The GERBUTM and AdjuphosTM groups showed good peak antibody responses, a booster effect of infection on antibody levels and a high level of inhibition of C2 activity in vitro. The Quil ATM group showed a high peak response and a booster effect of infection. Here, C2 is linked to infection.